Principal Financial Group
COGT icon

Principal Financial Group’s Cogent Biosciences COGT Stock Holding History

Principal Financial Group’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.33M Buy
135,191
+10,033
+8% +$371K ﹤0.01% 1716
2026
Q2 		$4.84M Buy
125,158
+41,214
+49% +$1.44M ﹤0.01% 1674
2026
Q1 		$3.23M Sell
83,944
-27,862
-25% -$1.03M ﹤0.01% 1743
2025
Q4 		$3.97M Sell
111,806
-160,654
-59% -$4.52M ﹤0.01% 1692
2025
Q3 		$3.91M Buy
+272,460
New +$3.23M ﹤0.01% 1674
2024
Q3 		– Sell
-16,211
Closed -$137K – 2264
2024
Q2 		$137K Sell
16,211
-3,704
-19% -$28.1K ﹤0.01% 2190
2024
Q1 		$134K Sell
19,915
-228
-1% -$1.41K ﹤0.01% 2239
2023
Q4 		$118K Sell
20,143
-1,124
-5% -$8.61K ﹤0.01% 2246
2023
Q3 		$207K Buy
21,267
+2,803
+15% +$33.2K ﹤0.01% 2160
2023
Q2 		$219K Buy
18,464
+1,379
+8% +$15.8K ﹤0.01% 2159
2023
Q1 		$184K Buy
17,085
+2,505
+17% +$32K ﹤0.01% 2196
2022
Q4 		$169K Buy
+14,580
New +$181K ﹤0.01% 2225

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Emerald Mutual Fund Advisers Trust
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $109B AUM 51.53% 1-Year Est. Return

Principal Financial Group's COGT Position: Q3 2026 in Review

Principal Financial Group increased its Cogent Biosciences (COGT) stake by 8% in Q3 2026, buying an estimated $371K and bringing the position to 135,191 shares worth $4.33M. The position accounts for ﹤0.01% of the portfolio, ranked #1716.

Principal Financial Group first reported a position in COGT in Q4 2022 and has held it in 12 quarters since. The position peaked at $4.84M in Q2 2026. 125 funds tracked by Wall St. Rank hold COGT as of Q3 2026.

  • Principal Financial Group held 135,191 shares of Cogent Biosciences worth $4.33M as of Q3 2026.
  • Principal Financial Group bought 10,033 Cogent Biosciences shares in Q3 2026, an estimated $371K.
  • Cogent Biosciences made up ﹤0.01% of Principal Financial Group's portfolio in Q3 2026, its #1716 holding.
  • Principal Financial Group first reported a position in Cogent Biosciences in Q4 2022 and has held it in 12 quarters since.
  • Principal Financial Group's Cogent Biosciences position peaked at $4.84M in Q2 2026.
  • 125 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.

Based on Principal Financial Group's 13F filing for Q3 2026, filed 2 Nov 2026.